Global High Throughput Screening Market Report 2017-2022 - $21,911.2 Million Opportunity Analysis And Industry Forecasts

DUBLIN, October 11, 2017 /PRNewswire/ --

The "High Throughput Screening Market - Global Opportunity Analysis And Industry Forecasts (2017-2022)" report has been added to Research and Markets' offering.

Global High Throughput Screening Market is expected to reach USD 21,911.2 million by 2022 supported by a CAGR of 8.0% during the forecast period of 2017 to 2022.

The global high throughput screening market is mainly driven by the increasing adoption of innovative approaches in pharmaceutical and biotechnology companies, growing investment by private equity firms and venture capitalists, rising government funding for various R&D activities, increasing healthcare spending, and technological advancements. Further, growing research in toxicology and stem cell research provide significant opportunities in this market. However, high cost for HTS, intricacy in the field of assay development, and government regulations for drug development obstructs the growth of this market to some extent.

Geographically, the global high throughput screening market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analysed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global high throughput screening market in 2016, followed by Asia-Pacific, and Europe.

The major share of the North American region is mainly attributed to the growing elderly population and increased Research and development expenditure in biopharmaceuticals and biotechnology industries. On the other hand, Asia-Pacific region is projected to grow at a fastest CAGR during the forecast period, due to increasing population, rising prevalence of various diseases, and growing R&D funding for the drug discovery and development.

Key Topics Covered:

1. Introduction

1.1. Market Ecosystem
1.2. Currency and Limitations
1.2.1. Currency
1.2.2. Limitations
1.3. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing Adoption of Innovative Approaches in Pharmaceutical and Biotechnology Companies
4.2.1.2. Increasing Investment by Private Equity Firms and Venture Capitalists
4.2.1.3. Rising Government Initiatives and Funding For R&D
4.2.1.4. Increasing Healthcare Spending
4.2.1.5. Technological Advancements
4.2.2. Restraints
4.2.2.1. High Cost of HTS
4.2.2.2. Intricacy in the Field of Assay Development
4.2.2.3. Government Regulations For Drug Development
4.2.3. Opportunities
4.2.3.1. Growing Toxicology and Stem Cell Research
4.3. Key industry Trends
4.3.1. Increasing Consolidation and Competition Among Vendors
4.3.2. Improved Automation and Miniaturization of HTS Techniques

5. High Throughput Screening Market, by Technology
5.1. Introduction
5.2. Cell-Based Assays
5.2.1. 2D Cell Culture
5.2.2. 3D Cell Culture
5.2.2.1. Scaffold Based Technology
5.2.2.1.1. Natural Polymer Hydrogels
5.2.2.1.1.1. Collagen
5.2.2.1.1.2. Gelatin
5.2.2.1.1.3. Hyaluronic Acid
5.2.2.1.1.4. Alginate
5.2.2.1.2. Synthetic Polymers
5.2.2.1.3. Solid Scaffolds
5.2.2.2. Scaffold Free Technology
5.2.2.2.1. Hanging Drop Plates
5.2.2.2.2. Microfluidics
5.2.2.2.3. Rotating Wall Vessel
5.2.2.2.4. Other Scaffold Free Technologies
5.2.3. Perfusion Cell Culture
5.3. Ultra High Throughout Screening
5.4. Label Free Technology
5.5. Lab On A Chip

6. High Throughput Screening Market, by Product and Services
6.1. Introduction
6.2. Consumables & Reagents
6.3. Instruments
6.3.1. Sample Preparation Instruments & Accessories
6.3.2. Liquid Handling Instruments
6.3.3. Readers
6.3.4. Other Instruments
6.4. Software & Services

7. High Throughput Screening Market, by Application
7.1. Introduction
7.2. Stem Cell Research
7.3. Toxicology Assessment
7.4. Target Identification
7.5. Primary Screening

8. High Throughput Screening Market, by End User
8.1. Introduction
8.2. Pharmaceuticals and Biotechnology Industry
8.3. Academics and Research institutes
8.4. Contract Research organizations
8.5. Other End Users

9. High Throughput Screening Market, by Geography

10. Competitive Landscape

11. Company Profiles

• AXXAM S.p.A. (Italy)
• Agilent technologies Inc. (U.S.)
• Aurora Biomed Inc. (Canada)
• Bio-Rad Laboratories Inc.(U.S.)
• Charles River Laboratories International Inc. (U.S.)
• Danaher Corporation (U.S.)
• Hamilton Company (U.S.)
• Merck KGaA (Germany)
• Perkin Elmer (U.S.)
• Tecan Trading AG (Switzerland)
• Thermo Fisher Scientific Inc. (U.S.)
  

For more information about this report visit https://www.researchandmarkets.com/research/53mb4z/high_throughput

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]